AIGH Capital Management LLC holds a concentrated book of 42 stocks worth $1.1B as of Q2 2026 (disclosed Aug 7, 2026, a ~38-day 13F lag). This quarter they opened Maxlinear Inc and trimmed Sandisk Corp. Their largest long position is Sandisk Corp at 31% of the equity book. They also disclosed $473.2M in put options (a bearish bet) and $9.0M in call options (bullish), shown separately below and excluded from the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as AIGH Capital Management LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| UBS Group AG | 70 / 42 | $3.1B |
| GEODE CAPITAL MANAGEMENT, LLC | 69 / 42 | $10.0B |
| BlackRock, Inc. | 68 / 42 | $37.1B |
| MORGAN STANLEY | 68 / 42 | $5.7B |
| VANGUARD CAPITAL MANAGEMENT LLC | 66 / 42 | $25.2B |
| VANGUARD FIDUCIARY TRUST CO | 66 / 42 | $2.5B |
| STATE STREET CORP | 63 / 42 | $59.3B |
| SBI Securities Co., Ltd. | 63 / 42 | $75.5M |
Ranked by how many of AIGH Capital Management LLC's top 42 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Sandisk Corp COM | $338.8M | 149.0K | 30.7% | ▼−26% Reduced · −51K sh | |
| 2 | Maxlinear Inc COM | $104.7M | 818.0K | 9.5% | ▲New New position | |
| 3 | Intel Corp COM | $87.1M | 623.5K | 7.9% | ▲New New position | |
| 4 | Digital Turbine Inc COM NEW | $84.5M | 6.55M | 7.6% | ▲+34% Added · +1.7M sh | |
| 5 | Silicon Motion Technology Co SPONSORED ADR | $48.0M | 144.0K | 4.3% | ▼−28% Reduced · −56K sh | |
| 6 | Clearfield Inc COM | $40.1M | 1.01M | 3.6% | ▲New New position | |
| 7 | Methode Electrs Inc COM | $31.8M | 1.68M | 2.9% | ▲New New position | |
| 8 | Amtech Sys Inc COM PAR $0.01N | $28.9M | 1.25M | 2.6% | ▲New New position | |
| 9 | Fennec Pharmaceuticals Inc COM | $26.7M | 2.49M | 2.4% | ▲+25% Added · +505K sh | |
| 10 | Kyverna Therapeutics Inc COM | $24.9M | 2.80M | 2.3% | ▲+40% Added · +796K sh | |
| 11 | Nyxoah S A SHS | $24.6M | 14.53M | 2.2% | ▲New New position | |
| 12 | Personalis Inc COM | $23.0M | 1.72M | 2.1% | ▼−41% Reduced · −1.2M sh | |
| 13 | Sophia Genetics Sa ORDINARY SHARES | $22.8M | 3.95M | 2.1% | ▲New New position | |
| 14 | 3D Sys Corp Del COM NEW | $22.0M | 7.27M | 2.0% | ▲New New position | |
| 15 | Vuzix Corp COM NEW | $19.6M | 6.75M | 1.8% | ▲+105% Added · +3.4M sh | |
| 16 | Abeona Therapeutics Inc COM NEW | $18.5M | 2.99M | 1.7% | ▼−3.6% Reduced · −113K sh | |
| 17 | Ardelyx Inc COM | $16.3M | 3.20M | 1.5% | ▲New New position | |
| 18 | Biodesix Inc COM | $15.3M | 678.3K | 1.4% | ▼−11% Reduced · −80K sh | |
| 19 | Spruce Biosciences Inc COM NEW | $13.5M | 250.0K | 1.2% | ▲New New position | |
| 20 | Castle Biosciences Inc COM | $13.0M | 545.1K | 1.2% | ▼−7.7% Reduced · −46K sh | |
| 21 | Vanda Pharmaceuticals Inc COM | $12.5M | 2.04M | 1.1% | ▼−26% Reduced · −706K sh | |
| 22 | Pelthos Therapeutics Inc COM SHS | $9.3M | 329.1K | 0.8% | ▲New New position | |
| 23 | Polypid Ltd COM | $7.6M | 1.50M | 0.7% | ▼−5.6% Reduced · −89K sh | |
| 24 | Verastem Inc COM NEW | $7.4M | 1.93M | 0.7% | ▼−3.6% Reduced · −73K sh | |
| 25 | Broadwind Inc COM NEW | $5.6M | 1.16M | 0.5% | ▲New New position | |
| 26 | Aeye Inc CL A NEW | $5.6M | 3.85M | 0.5% | ▲New New position | |
| 27 | Orthopediatrics Corp COM | $5.2M | 269.8K | 0.5% | ▲New New position | |
| 28 | Apyx Medical Corporation COM | $5.1M | 1.13M | 0.5% | ▲+2.1% Added · +23K sh | |
| 29 | Ideal PWR Inc COM NEW | $4.8M | 894.7K | 0.4% | ▼−24% Reduced · −287K sh | |
| 30 | Talphera Inc COM NEW | $4.7M | 4.60M | 0.4% | ▼−1.3% Reduced · −60K sh | |
| 31 | Tigo Energy Inc COM | $4.6M | 1.99M | 0.4% | ▼−73% Reduced · −5.3M sh | |
| 32 | Energous Corp COM NEW | $4.4M | 182.0K | 0.4% | ▼−15% Reduced · −33K sh | |
| 33 | Renovorx Inc COM NEW | $4.3M | 4.41M | 0.4% | ▲+19% Added · +699K sh | |
| 34 | Richardson Electrs Ltd COM | $3.8M | 200.4K | 0.3% | ▲New New position | |
| 35 | Neuraxis Inc COM | $3.8M | 519.9K | 0.3% | ▲+30% Added · +120K sh | |
| 36 | Coya Therapeutics Inc COMMON STOCK | $3.7M | 631.9K | 0.3% | ▼−35% Reduced · −343K sh | |
| 37 | Identiv Inc COM NEW | $3.7M | 1.45M | 0.3% | ▲+254% Added · +1.0M sh | |
| 38 | Elutia Inc CL A COM | $2.6M | 2.70M | 0.2% | ▼−25% Reduced · −900K sh | |
| 39 | Aprea Therapeutics Inc COM NEW | $815K | 1.02M | 0.1% | —Held | |
| 40 | Biofrontera Inc COM NEW | $700K | 739.9K | 0.1% | ▼−19% Reduced · −175K sh | |
| 41 | Quoin Pharmaceuticals Ltd SPONSORED ADS | $339K | 70.0K | 0.0% | ▲+37% Added · +19K sh | |
| 42 | NN Inc COM | $41K | 11.5K | 0.0% | ▲New New position |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1835943/holdings"
Use Arkolith to show AIGH Capital Management LLC's latest holdings, largest changes, and filing provenance.
Put / call positions from the 13F — totals include every disclosed option leg
| Type | Underlying | Notional value | Underlying shares |
|---|---|---|---|
| PUT · bearish | ISHARES RUSSELL 2000 ETFIWM | $331.4M | 1.1M |
| PUT · bearish | INVESCO QQQ TRUST SERIES 1QQQ | $141.8M | 193K |
| CALL · bullish | DOMO INC - CLASS BDOMO | $9.0M | 2.9M |
13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 7, 2026 | 89 | $1.6B | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 30, 2026 | 85 | $733.2M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 2, 2026 | 68 | $413.1M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 31, 2025 | 76 | $354.9M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 29, 2025 | 70 | $222.3M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 | 81 | $241.6M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 12, 2025 | 76 | $319.8M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 80 | $354.6M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.